60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Short-Term Debt : $0.01 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals Short-Term Debt?

60 Degrees Pharmaceuticals's Short-Term Debt for the quarter that ended in Mar. 2024 was $0.01 Mil.

60 Degrees Pharmaceuticals's quarterly Short-Term Debt stayed the same from Sep. 2023 ($0.01 Mil) to Dec. 2023 ($0.01 Mil) and stayed the same from Dec. 2023 ($0.01 Mil) to Mar. 2024 ($0.01 Mil).

60 Degrees Pharmaceuticals's annual Short-Term Debt increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($21.14 Mil) but then declined from Dec. 2022 ($21.14 Mil) to Dec. 2023 ($0.01 Mil).

60 Degrees Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

60 Degrees Pharmaceuticals Short-Term Debt Chart

60 Degrees Pharmaceuticals Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

21.14

0.01

60 Degrees Pharmaceuticals Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial							22.62	24.65	0.01	0.01	0.01

60 Degrees Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

60 Degrees Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

SXTP:USA

Address

1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036

Website

https://www.60degreespharma.com

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.